These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27033733)

  • 1. Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System.
    Forsyth R; Vockley CW; Edick MJ; Cameron CA; Hiner SJ; Berry SA; Vockley J; Arnold GL;
    Mol Genet Metab; 2016 May; 118(1):15-20. PubMed ID: 27033733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening.
    Arnold GL; Salazar D; Neidich JA; Suwannarat P; Graham BH; Lichter-Konecki U; Bosch AM; Cusmano-Ozog K; Enns G; Wright EL; Lanpher BC; Owen NN; Lipson MH; Cerone R; Levy P; Wong LJ; Dezsofi A
    Mol Genet Metab; 2012 Aug; 106(4):439-41. PubMed ID: 22658692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database.
    Lam C; Carter JM; Cederbaum SD; Neidich J; Gallant NM; Lorey F; Feuchtbaum L; Wong DA
    Mol Genet Metab; 2013 Dec; 110(4):477-83. PubMed ID: 24103308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.
    Koeberl DD; Millington DS; Smith WE; Weavil SD; Muenzer J; McCandless SE; Kishnani PS; McDonald MT; Chaing S; Boney A; Moore E; Frazier DM
    J Inherit Metab Dis; 2003; 26(1):25-35. PubMed ID: 12872837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?
    Wang H; Liu S; Wang B; Yang Y; Yu B; Wang L; Wang T
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1321-1326. PubMed ID: 31730530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.
    Grünert SC; Stucki M; Morscher RJ; Suormala T; Bürer C; Burda P; Christensen E; Ficicioglu C; Herwig J; Kölker S; Möslinger D; Pasquini E; Santer R; Schwab KO; Wilcken B; Fowler B; Yue WW; Baumgartner MR
    Orphanet J Rare Dis; 2012 May; 7():31. PubMed ID: 22642865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.
    Rips J; Almashanu S; Mandel H; Josephsberg S; Lerman-Sagie T; Zerem A; Podeh B; Anikster Y; Shaag A; Luder A; Staretz Chacham O; Spiegel R
    J Inherit Metab Dis; 2016 Mar; 39(2):211-7. PubMed ID: 26566957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-methylcrotonyl-CoA carboxylase deficient human skin fibroblast transcriptome reveals underlying mitochondrial dysfunction and oxidative stress.
    Zandberg L; van Dyk HC; van der Westhuizen FH; van Dijk AA
    Int J Biochem Cell Biol; 2016 Sep; 78():116-129. PubMed ID: 27417235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.
    Morscher RJ; Grünert SC; Bürer C; Burda P; Suormala T; Fowler B; Baumgartner MR
    Mol Genet Metab; 2012 Apr; 105(4):602-6. PubMed ID: 22264772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency.
    Arnold GL; Koeberl DD; Matern D; Barshop B; Braverman N; Burton B; Cederbaum S; Fiegenbaum A; Garganta C; Gibson J; Goodman SI; Harding C; Kahler S; Kronn D; Longo N
    Mol Genet Metab; 2008 Apr; 93(4):363-70. PubMed ID: 18155630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening.
    Ficicioglu C; Payan I
    Pediatrics; 2006 Dec; 118(6):2555-6. PubMed ID: 17142544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening.
    Kör D; Mungan NÖ; Yılmaz BŞ; Öktem M
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):669-71. PubMed ID: 25381946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment.
    Stadler SC; Polanetz R; Maier EM; Heidenreich SC; Niederer B; Mayerhofer PU; Lagler F; Koch HG; Santer R; Fletcher JM; Ranieri E; Das AM; Spiekerkötter U; Schwab KO; Pötzsch S; Marquardt I; Hennermann JB; Knerr I; Mercimek-Mahmutoglu S; Kohlschmidt N; Liebl B; Fingerhut R; Olgemöller B; Muntau AC; Roscher AA; Röschinger W
    Hum Mutat; 2006 Aug; 27(8):748-59. PubMed ID: 16835865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-methylcrotonyl-CoA carboxylase deficiency in an infant with cardiomyopathy, in her brother with developmental delay and in their asymptomatic father.
    Visser G; Suormala T; Smit GP; Reijngoud DJ; Bink-Boelkens MT; Niezen-Koning KE; Baumgartner ER
    Eur J Pediatr; 2000 Dec; 159(12):901-4. PubMed ID: 11131348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening.
    Dantas MF; Suormala T; Randolph A; Coelho D; Fowler B; Valle D; Baumgartner MR
    Hum Mutat; 2005 Aug; 26(2):164. PubMed ID: 16010683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow up and gene mutation analysis in cases suspected as 3-methylcrotonyl-coenzyme A carboxylase deficiency by neonatal screening].
    Ye J; Gong L; Han L; Qiu W; Zhang H; Gao X; Jin J; Xu H; Gu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):409-14. PubMed ID: 25190158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Methylcrotonyl-CoA carboxylase deficiency: Mutational spectrum derived from comprehensive newborn screening.
    Fonseca H; Azevedo L; Serrano C; Sousa C; Marcão A; Vilarinho L
    Gene; 2016 Dec; 594(2):203-210. PubMed ID: 27601257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum in eight Korean patients with 3-methylcrotonyl-CoA carboxylase deficiency.
    Cho SY; Park HD; Lee YW; Ki CS; Lee SY; Sohn YB; Park SW; Kim SH; Ji S; Kim SJ; Choi EW; Kim CH; Ko AR; Paik KH; Lee DH; Jin DK
    Clin Genet; 2012 Jan; 81(1):96-8. PubMed ID: 22150417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.